Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Glioma × Azacitidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 128 Myelodysplastic Syndromes 53 Leukemia 24 Leukemia, Myelomonocytic, Chronic 20 Recurrence 11 Leukemia, Biphenotypic, Acute 7 Myeloproliferative Disorders 6 Lymphoma, T-Cell, Peripheral 6 Leukemia, Monocytic, Acute 6 Carcinoma, Non-Small-Cell Lung 6 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm, Residual 5 Anemia, Refractory, with Excess of Blasts 5 Neoplasms 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Erythroblastic, Acute 4 Congenital Abnormalities 4 Prostatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Breast Neoplasms 3 Primary Myelofibrosis 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Lymphoma, Follicular 2

Interventions

Temozolomide 59 Bevacizumab 37 Radiotherapy 19 Magnetic Resonance Spectroscopy 18 Irinotecan 16 Carboplatin 10 Specimen Handling 9 Carmustine 9 olaparib 6 X-Rays 6 Surgical Procedures, Operative 6 Phantoms, Imaging 6 Cyclophosphamide 6 Thalidomide 5 Nuclear Medicine Department, Hospital 5 Nivolumab 5 Biopsy 5 trametinib 4 pembrolizumab 4 Radiation 4 Lomustine 4 Everolimus 4 Cisplatin 4 Aminolevulinic Acid 4 sargramostim 3 poly ICLC 3 palbociclib 3 ivosidenib 3 fluorodopa F 18 3 erdafitinib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03666559 2024-02-29

AGIR

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡